Antagonistic regulation of α-actinin alternative splicing by CELF proteins and polypyrimidine tract binding protein

被引:91
作者
Gromak, N
Matlin, AJ
Cooper, TA
Smith, CWJ
机构
[1] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England
[2] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
关键词
polypyrimidine tract binding protein; PTB; CUG-BP; bruno-like proteins; hnRNP;
D O I
10.1261/rna.2191903
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The alpha-actinin gene has a pair of alternatively spliced exons. The smooth muscle (SM) exon is repressed in most cell types by polypyrimidine tract binding protein (PTB). CELF ((C) under bar UG-BP and (E) under bar TR3-(l) under bar ike (f) under bar actors) family proteins, splicing regulators whose activities are altered in myotonic dystrophy, were found to coordinately regulate selection of the two alpha-actinin exons. CUG-BP and ETR3 activated the SM exon, and along with CELF4 they were also able to repress splicing of the NM (nonmuscle) exon both in vivo and in vitro. Activation of SM exon splicing was associated with displacement of PTB from the polypyrimidine tract by binding of CUG-BP at adjacent sites. Our data provides direct evidence for the activity of CELF proteins as both activators and repressors of splicing within a single-model system of alternative splicing, and suggests a model whereby a-actinin alternative splicing is regulated by synergistic and antagonistic interactions between members of the CELF and PTB families.
引用
收藏
页码:443 / 456
页数:14
相关论文
共 58 条
  • [1] Protein diversity from alternative splicing: A challenge for bioinformatics and post-genome biology
    Black, DL
    [J]. CELL, 2000, 103 (03) : 367 - 370
  • [2] Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases
    Blencowe, BJ
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (03) : 106 - 110
  • [3] Burge CB, 1999, RNA WORLD, P525
  • [4] REGULATION OF ALTERNATIVE SPLICING IN-VIVO BY OVEREXPRESSION OF ANTAGONISTIC SPLICING FACTORS
    CACERES, JF
    STAMM, S
    HELFMAN, DM
    KRAINER, AR
    [J]. SCIENCE, 1994, 265 (5179) : 1706 - 1709
  • [5] Alternative splicing:: multiple control mechanisms and involvement in human disease
    Cáceres, JF
    Kornblihtt, AR
    [J]. TRENDS IN GENETICS, 2002, 18 (04) : 186 - 193
  • [6] hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing
    Caputi, M
    Mayeda, A
    Krainer, AR
    Zahler, AM
    [J]. EMBO JOURNAL, 1999, 18 (14) : 4060 - 4067
  • [7] Listening to silence and understanding nonsense: Exonic mutations that affect splicing
    Cartegni, L
    Chew, SL
    Krainer, AR
    [J]. NATURE REVIEWS GENETICS, 2002, 3 (04) : 285 - 298
  • [8] Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing
    Charlet-B, N
    Savkur, RS
    Singh, G
    Philips, AV
    Grice, EA
    Cooper, TA
    [J]. MOLECULAR CELL, 2002, 10 (01) : 45 - 53
  • [9] Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing
    Charlet-B, N
    Logan, P
    Singh, G
    Cooper, TA
    [J]. MOLECULAR CELL, 2002, 9 (03) : 649 - 658
  • [10] Developmentally-regulated expression of mNapor encoding an apoptosis-induced ELAV-type RNA binding protein
    Choi, DK
    Ito, T
    Tsukahara, F
    Hirai, M
    Sakaki, Y
    [J]. GENE, 1999, 237 (01) : 135 - 142